Commentary

Podcast

Camidge and Datta Detail the Career of an “Opportunistic Nomad”

Author(s):

D. Ross Camidge, MD, PhD,Jashodeep Datta, MD

In Partnership With:

Drs Camidge and Datta highlight Dr Datta’s career as a surgeon-scientist and research that aims to improve systemic therapies for pancreatic cancer.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences.

In this episode, Dr Camidge sits down with Jashodeep Datta, MD, to discuss pivotal moments in Dr Datta’s oncology career. Dr Datta is an assistant professor of surgery, co-leader of the Gastrointestinal Site Disease Group at the University of Miami Sylvester Comprehensive Cancer Center, and associate director of Translational Research at the Sylvester Pancreatic Cancer Research Institute in Florida.

Drs Camidge and Datta highlight the nuances of Dr Datta’s career as a surgeon-scientist, the unexpected intersections between music and surgery, his research that aims to improve systemic therapies for pancreatic cancer that will in turn improve surgical operations, and more.

Related Videos
Janaki Neela Sharma, MD, University of Miami
Janaki Neela Sharma, MD, discusses CheckMate 901, and where nivolumab plus chemotherapy fits into the advanced urothelial cancer treatment paradigm.
Janaki Neela Sharma, MD
Janaki Neela Sharma, MD, assistant professor, clinical medicine, Genitourinary Medical Oncology, University of Miami Health Systems
Cindy Medina Pabon, MD, assistant professor, Sylvester Cancer Center, University of Miami; assistant lead, GI Cancer Clinical Research, Gastrointestinal Medical Oncology, University of Miami Health Systems
Ryan Hood, BA, MD/MPH student, University of Miami Miller School of Medicine
Justin M. Watts, MD
C. Ola Landgren, MD, PhD
Justin M. Watts, MD
Mikkael A. Sekeres, MD
Related Content
Cindy M. Pabon, MD
November 20th 2024

Phase 3 Trial Data Inform Advancements in Targeted Therapy for Gastric/GEJ Cancers

D. Ross Camidge, MD, PhD; Rahul Gosain, MD, MBA, medical director, Wilmot Cancer Institute at Webster, director, Wilmot Cancer Institute Regional Infusion services, assistant professor, clinical medicine, Department of Medicine, Hematology/Oncology, University of Rochester
November 20th 2024

How the Drive to Connect the Oncology Community Built an Educational Podcast Platform: With D. Ross Camidge, MD, PhD; and Rahul Gosain, MD, MBA

Janaki Neela Sharma, MD, on urothelial cancer
November 7th 2024

Enfortumab Vedotin Plus Pembrolizumab Leads to Shifts in Frontline Metastatic Urothelial Cancer Management

D. Ross Camidge, MD, PhD; Duncan McLaren, MBBS, BSc, FRCR, FRCP, consultant clinical oncologist, Spire Edinburgh Hospitals Murrayfield and Shawfair Park, professor, Edinburgh Cancer Research Centre, The University of Edinburgh
November 13th 2024

Clinical Oncology Bridges Gaps Between Medical Oncology, Radiation Oncology, and Clinical Research: With D. Ross Camidge, MD, PhD; and Duncan McLaren, MBBS, BSc, FRCR, FRCP

Breast cancer Image Credit: © Axel Kock - stock.adobe.com
October 29th 2024

Higher Breast Cancer Rates Among Caribbean Woman May be Linked to Changes in Reproductive Health

Samuel A. Kareff, MD, MPH, outgoing chief fellow, hematology and medical oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital
October 22nd 2024

The Importance of Hematology/Medical Oncology Fellowship